Aptagen, LLC
SQ-2 (ID# 8066)
RNA
ALPPL-2
Protein
22.25-24.74 nM (reported value)
4.5 g/L glucose, 5 mmol/L MgCl2, 0.1 mg/mL yeast tRNA, and 1 mg/mL bovine serum albumin (BSA) in Dulbecco's PBS
4°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-rAprUprAprCprCprAprGprCprUprUprAprUprUprCprAprAprUprUprGprCprCprUprGprAprAprAprAprGprCprUprAprUprCprGprCprCprCprAprAp rUprUprCprGprCprAprGprUprGprAprUprAprUprCprCprUprUprUprAprAprGprAprUprAprGprUprAprAprGprUprGprCprAprAprUprCprUp-3'
76
22995.6
711400
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Dua, P., Kang, H. S., Hong, S.-M., Tsao, M.-S., Kim, S., & Lee, D. -k. (2013). Alkaline Phosphatase ALPPL-2 Is a Novel Pancreatic Carcinoma-Associated Protein. Cancer Research, 73(6), 1934–1945. doi:10.1158/0008-5472.can-12-3682
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.